100 related articles for article (PubMed ID: 28351326)
1. Suppression of p53-inducible gene 3 is significant for glioblastoma progression and predicts poor patient prognosis.
Quan J; Li Y; Jin M; Chen D; Yin X; Jin M
Tumour Biol; 2017 Mar; 39(3):1010428317694572. PubMed ID: 28351326
[TBL] [Abstract][Full Text] [Related]
2. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma.
Shi Y; Chen C; Zhang X; Liu Q; Xu JL; Zhang HR; Yao XH; Jiang T; He ZC; Ren Y; Cui W; Xu C; Liu L; Cui YH; Yu SZ; Ping YF; Bian XW
Clin Cancer Res; 2014 Apr; 20(7):1803-13. PubMed ID: 24523440
[TBL] [Abstract][Full Text] [Related]
3. Roles of zinc-fingers and homeoboxes 1 during the proliferation, migration, and invasion of glioblastoma cells.
Kwon RJ; Han ME; Kim YJ; Kim YH; Kim JY; Liu L; Heo W; Oh SO
Tumour Biol; 2017 Mar; 39(3):1010428317694575. PubMed ID: 28351300
[TBL] [Abstract][Full Text] [Related]
4. SEMA6A is a prognostic biomarker in glioblastoma.
Zhao J; Tang H; Zhao H; Che W; Zhang L; Liang P
Tumour Biol; 2015 Nov; 36(11):8333-40. PubMed ID: 26014517
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis.
Liu X; Kang J; Liu F; Wen S; Zeng X; Liu K; Luo Y; Ji X; Zhao S
Tumour Biol; 2016 May; 37(5):6323-30. PubMed ID: 26628298
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells.
Mughal AA; Grieg Z; Skjellegrind H; Fayzullin A; Lamkhannat M; Joel M; Ahmed MS; Murrell W; Vik-Mo EO; Langmoen IA; Stangeland B
Mol Cancer; 2015 Aug; 14():160. PubMed ID: 26292663
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
8. Neuroglobin functions as a prognostic marker and promotes the tumor growth of glioma via suppressing apoptosis.
Zhang B; Chang M; Wang J; Liu Y
Biomed Pharmacother; 2017 Apr; 88():173-180. PubMed ID: 28103511
[TBL] [Abstract][Full Text] [Related]
9. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
11. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
[TBL] [Abstract][Full Text] [Related]
12. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
13. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
14. Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53.
Kraus A; Gross MW; Knuechel R; Münkel K; Neff F; Schlegel J
J Neurosurg; 2000 Nov; 93(5):863-72. PubMed ID: 11059670
[TBL] [Abstract][Full Text] [Related]
15. High expression of TIG3 predicts poor survival in patients with primary glioblastoma.
Wang H; Xu H; Xu T; Tan C; Jiang M; Chen Y; Hu X; Zhou J; Shen J; Qin R; Hu D; Huang Q; Wang M; Wang L; Duan D; Yan Y; Chen J
Tumour Biol; 2017 Jun; 39(6):1010428317712135. PubMed ID: 28639915
[TBL] [Abstract][Full Text] [Related]
16. LINC00174 is a favorable prognostic biomarker in glioblastoma via promoting proliferative phenotype.
Wang Z; Wang Q; Bao Z; Guo L; Chen H; Lv T; Xu T; Zhang X; Zhou C; Sun L
Cancer Biomark; 2020; 28(4):421-427. PubMed ID: 32390602
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
Yong WH; Shabihkhani M; Telesca D; Yang S; Tso JL; Menjivar JC; Wei B; Lucey GM; Mareninov S; Chen Z; Liau LM; Lai A; Nelson SF; Cloughesy TF; Tso CL
PLoS One; 2015; 10(10):e0141334. PubMed ID: 26506620
[TBL] [Abstract][Full Text] [Related]
18. TIPE1 promotes cervical cancer progression by repression of p53 acetylation and is associated with poor cervical cancer outcome.
Zhao P; Pang X; Jiang J; Wang L; Zhu X; Yin Y; Zhai Q; Xiang X; Feng F; Xu W
Carcinogenesis; 2019 Jun; 40(4):592-599. PubMed ID: 30445600
[TBL] [Abstract][Full Text] [Related]
19. High expression of PCBP2 is associated with progression and poor prognosis in patients with glioblastoma.
Luo K; Zhuang K
Biomed Pharmacother; 2017 Oct; 94():659-665. PubMed ID: 28787701
[TBL] [Abstract][Full Text] [Related]
20. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
